To confirm this hypothesis, we carried out the experiments in the presence of AF, a well‐known inhibitor, at submicromolar level, of TrxR, as previously stated, or in the presence of BCNU, a chemotherapeutic agent acting as an inhibitor of GR.41 This evidence concerns the gene GSR and atrial fibrillation.